ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EVOTF Evotec SE (PK)

9.34
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Evotec SE (PK) USOTC:EVOTF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.34 9.34 9.34 0.00 00:00:00

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

12/04/2022 1:16pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE MONTH OF APRIL 2022

 

COMMISSION FILE NUMBER 001-34041

 

Evotec SE

(Translation of registrant’s name into English)

 

Essener Bogen 7

22419 Hamburg

Germany

Tel: +49 40 560810

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20‑F or Form 40‑F: Form 20‑F ☒     Form 40‑F ☐

 

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(7): ☐

 

On April 12, 2022, Evotec SE (the “Company”) reported financial results and corporate updates for the fiscal year ended 31 December 2021. The press release is attached hereto as Exhibit 99.1. An accompanying investor presentation is attached hereto as Exhibit 99.2.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of s the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Evotec SE

       

Date: April 12, 2022

By: /s/ Enno Spillner

 

Name:

Enno Spillner  
  Title: Chief Financial Officer  

 

 

2

 

 

EXHIBIT INDEX

 

Exhibit

 

Description of Exhibit

99.1

 

Evotec SE Fiscal Year 2021 Results: “Setting the Pace” on the Data-Driven R&D Autobahn to Cures

99.2

 

Evotec SE: Setting the pace… Bringing Probabilities of Success up with the right platforms & technologies

 

 

 

3

 

1 Year Evotec (PK) Chart

1 Year Evotec (PK) Chart

1 Month Evotec (PK) Chart

1 Month Evotec (PK) Chart

Your Recent History

Delayed Upgrade Clock